Our part time, online course covers all aspects of delivering care to patients. You will study treatment modalities, biological, psychosocial and ethical perspectives. Well-established cancer institutes and oncological and palliative care experts developed and deliver the course. You will enjoy a comprehensive and intellectually stimulating experience wherever you are worldwide.
This course is designed to provide oncology, palliative care and oncology pharmaceutical industry professionals with detailed knowledge about the interrelationship between oncology and clinical cancer service provision.
Through the course you will develop clinical leadership, clinical excellence and the ability to cultivate interdisciplinary collaboration in the delivery of evidence based oncology and palliative care. This includes sharing mutually valuable information to help develop clinical practice. You will be introduced to the basis of research in oncology and palliative care, preparing you for further research within the fields.
Our students include:
Newcastle and the North East of England have a tremendous amount of oncological and palliative care expertise and all our teaching staff are healthcare professionals actively involved in research. This knowledge base provides a comprehensive, intellectually stimulating, and extremely useful educational experience to all students involved in it.
The course is led by:
The course is taught online, so you can choose to study anytime and anywhere. This flexibility means that you can fit your studies around your other commitments, plus learning online will develop your online literacy as a transferable skill.
You will be given an account on Blackboard, our managed learning environment, and an email address. Blackboard is accessible across a variety of operating systems and browsers, check that your equipment is compatible. Our materials and supporting reading are accessible across a variety of devices including desktop computers, tablets and mobile phones.
Online delivery is structured in weekly topics, guiding your learning via tutorials, videos, discussions and formative exercises. The courses are full of interactive exercises and activities, including immediate feedback from automatically scored activities and practices. You can discuss the course, ask questions and get help with problems through the course discussion groups or through emailing your module leader. The networking opportunities of this course give you a multi-disciplinary awareness to your studies.
Your first task will be to complete a short induction module before studying between 10 and 30 credits per semester. You will be assessed in a variety of ways including:
Each 10 credit module is the equivalent to 100 hours of notional study time, which includes:
Approximate semester start dates are as follows:
Semester dates can be found on the University Calendar.
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.
This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.
Students undertake modules to the value of 180 credits.
The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).
A Postgraduate Diploma (120 credits, full-time nine months) is offered.
A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.
Teaching and learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).
Further information on modules and degree structure is available on the department website: Cancer MSc
The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.
UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.
The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Cancer Institute
80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.
Our Nursing Studies postgraduate students have an outstanding record of contributing to the knowledge and evidence base in nursing. The programme also has a strong tradition of welcoming students from overseas, as well as the UK.
Our main areas of research activity and development currently relate to the themes of experience of health and illness, and organisation and policy for person-centred care.
The main areas of study we can supervise for doctoral research are:
We have expertise in a range of qualitative and quantitative and mixed methods research approaches.
Read more about our research on our website:
The MSc by Research in Nursing Studies provides students with an advanced understanding of research design, data collection and data analysis issues in nursing.
The programme is designed for qualified practitioners and graduates and enables students to develop their understanding of debates about research, evidence and practice in relation to nursing and related fields.
The distinctive features of this degree include:
The PhD/MPhil programme is an advanced research degree enabling you to conduct in-depth independent research on a topic of your choice.
Normal progression for PhD/MPhil in nursing involves spending the first year preparing for the main research work; taking research training courses, reviewing literature, and developing your research proposal.
Progression to year two of the programme is dependent on a satisfactory outcome from a review board. Typically, the second year is spent doing the body of the research, usually empirical data collection and analysis, and the third year is spent completing the analysis and writing the thesis.
You will be able to attend a wide range of postgraduate seminar courses from across the College of Arts, Humanities & Social Sciences. There is the opportunity to attend other courses in Nursing Studies as well as a wide range of postgraduate seminar courses within the College of Arts, Humanities & Social Sciences and related disciplines across the University.
Nursing studies PhD and MPhil students join a 50-year tradition of scholarship. Our students share courses with others from a wide variety of disciplines.
Those doing higher degrees by research usually undertake research training courses, as well as carrying out their own research. PhD students normally have two supervisors, one of whom may be from a different discipline relevant to your interests.
Our Cancer MRes is a research-based course with a taught component that is equivalent to an MSc. It provides a springboard into a career that involves a working knowledge of scientific research.
The course is designed for graduates with a BSc in the life sciences or other science disciplines, and for intercalating and fully qualified MBBS or BDS students. It can be taken either as a stand-alone qualification or as an entry route onto a PhD or MD.
The taught component of the course includes subject-specific content in the area of cancer research. You have the flexibility to develop your own bespoke course by selecting additional, complementary modules. You will also receive itraining in general research principles, and other professional and key skills. Subject-based modules cover:
-Clinical and pathological aspects of cancer
-Molecular mechanisms that establish and promote cancer
-Current treatments and how research translates into novel treatments
Your research project comprises the major element of the course. This project will involve 24 weeks of research in an area of cancer research under the supervision of an expert academic researcher in the field. Projects are undertaken in laboratories actively engaged in cancer research. Examples are:
-Roles of tumour suppressor genes
-Bio-molecular basis of hormone-dependent cancers
-Evaluation of novel bio-drugs.
The course allows you to experience an internationally competitive research area, predominantly in academia but also potentially in industry.
Cancer MRes is closely linked to a suite of MRes courses that you may also be interested in. See Programme information in our online Prospectus for full details.
Our Medical Sciences Graduate School is dedicated to providing you with information, support and advice throughout your research degree studies. We can help and advise you on a variety of queries relating to your studies, funding or welfare.
Our Research Student Development Programme supports and complements your research whilst developing your professional skills and confidence.
You will make an on-going assessment of your own development and training needs through personal development planning (PDP) in the ePortfolio system. Our organised external events and development programme have been mapped against the Vitae Researcher Development Framework to help you identify how best to meet your training and development needs.
If you are a healthcare professional, this course gives you the knowledge and expertise to develop as a specialist prostate cancer practitioner. Through online learning you learn how to provide, promote and develop high standards of care.
The postgraduate certificate stage focuses on developing your clinical knowledge and skills. The prostate cancer module gives you an in-depth understanding of managing the stages of the disease including • the physical and psychosocial impact • treatment • the needs of those affected • how these needs can be addressed.
As advanced communication is essential to your clinical role, you also undertake a module on this subject. This helps you develop your knowledge of the concepts underpinning advanced communication strategies used in practice and encourages you to reflect on your skills development in this area too.
During the postgraduate diploma stage you develop your understanding of the wider specialist and advanced practice role in areas such as • leadership • peer support • education • service development and improvement.
You also expand your knowledge of high risk or high priority areas in practice, which you identify as relevant to your own local practice, such as • care of African Caribbean men • needs relating to sexual function • survivorship • end of life care.
This stage of the course also prepares you for undertaking research by improving your understanding of research methods and helping you develop a research question for investigation.
In the final masters stage you research a specific area of interest relevant to your professional role and priorities in practice. This enables you to specialise in your chosen topic, develop expertise and hopefully influence practice or policy.
Throughout your studies you are encouraged to reflect on your role as
You also evaluate your own practice and the practice of others to help you develop ideas for service improvement within your practice and workplace.
This is primarily a distance learning course using online learning. You must have internet access and be prepared to engage with technology. We supply you with a range of online learning and teaching resources, including access to library resources and information databases.
Each module provides clear guidance on how to approach your self-directed study. This learning is enhanced by online, tutor facilitated group discussions allowing you to share views and practice experiences with other students. These sessions are a popular and valuable learning resource, and are also used to support you in your final marked assessment.
Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company number 2653887.
The postgraduate certificate (PgCert) is achieved by successfully completing 60 credits.
The postgraduate diploma (PgDip) is achieved by successfully completing 120 credits.
The masters (MSc) award is achieved by successfully completing 180 credits.
Postgraduate certificate core modules
Postgraduate diploma core modules
You choose a further 30 credits from the following modules:
If you are a specialist practitioner in prostate cancer care, this course enables you to continue your academic and professional development and validate your role. You can tailor your learning, allowing you to specialise in areas such as palliative and end of life care, survivorship and rehabilitation.
If working towards a specialist practitioner role, the course equips you with core knowledge and skills to help you perform at the necessary practice level.
The course provides academic and professional skills relevant to the role of an advanced/specialist practitioner, as defined by professional bodies such as the Royal College of Nursing and the College of Radiographers.
The course also provides opportunities to be involved in research and service development activities in a professional, clinical or academic setting. You are encouraged to share your learning and research through article publication or conference presentation, helping to raise your profile in this field.
As well as specialist clinical roles, you may also pursue academic teaching or research careers in the UK or internationally.
Translational Cancer Medicine enables you to gain detailed knowledge and understanding of research methods applied to rational drug design, clinical study design, molecular and cell biology, tumour immunology, genetics and cancer imaging. You'll gain practical experience through two six-month laboratory rotations.
The Translational Cancer Medicine MRes study pathway offers unique opportunities for you to join experienced research teams and work on particular projects from the outset. This course will allow you to develop an in-depth understanding of research methods, and of how theoretical academic studies and skills relate to research projects.
You will explore Fundamentals of Translational Cancer Medicine, providing you with advanced knowledge and skills to conceptualise, design, conduct and critically appraise specialist research. You will gain hands on research experience in two six month lab projects.
We use lectures, seminars and group meetings to deliver most of the modules on the course.
On average teaching consists of:
You will also be expected to undertake a significant amount of independent study.
Typically, 1 credit equates to ten hours of work.
Throughout the year, you will also attend literature reviews and journal clubs that the labs/departments organise, as well as any other internal or external seminars deemed relevant to your projects/assignments.
The primary method of assessment for this course is a combination of written essays, a thesis (research report), a presentation/Q&A session regarding the research report and a draft of a scientific paper.
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they are subject to change.
Occupational health clearance will be required for some of the projects.
Future PhD studies. Clinical and non-clinical academic careers in cancer medicine.
Edinburgh Cancer Research UK Centre (ECRC) strives to take a comprehensive approach to cancer research, combining both laboratory-based research and clinical approaches.
Overall the centre studies the genetic and biological basis of cancer and disease pathology, and devises and test new forms of therapy arising from our basic, translational and clinical research programs.
Our ultimate aim is to carry out high quality research into effective cancer prevention, diagnosis and treatment, as well as the symptoms associated with cancer.
ECRC is part of the Edinburgh Medical School's Deanery of Molecular, Genetic and Population Health Sciences at the Western General Hospital. This centre, as part of a unit of Hospital-Based Clinical Subjects, was rated 5* in the most recent Research Assessment Exercise.
We have 18 academic staff, 40 research staff, 35 support staff and 22 students.